Meling, D.; Ehrenkranz, R.; Nayak, S.M.; Aicher, H.D.; Funk, X.; van Elk, M.; Graziosi, M.; Bauer, P.R.; Scheidegger, M.; Yaden, D.B.
Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for Depression. Psychoactives 2024, 3, 215-234.
https://doi.org/10.3390/psychoactives3020014
AMA Style
Meling D, Ehrenkranz R, Nayak SM, Aicher HD, Funk X, van Elk M, Graziosi M, Bauer PR, Scheidegger M, Yaden DB.
Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for Depression. Psychoactives. 2024; 3(2):215-234.
https://doi.org/10.3390/psychoactives3020014
Chicago/Turabian Style
Meling, Daniel, Rebecca Ehrenkranz, Sandeep M. Nayak, Helena D. Aicher, Xaver Funk, Michiel van Elk, Marianna Graziosi, Prisca R. Bauer, Milan Scheidegger, and David B. Yaden.
2024. "Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for Depression" Psychoactives 3, no. 2: 215-234.
https://doi.org/10.3390/psychoactives3020014
APA Style
Meling, D., Ehrenkranz, R., Nayak, S. M., Aicher, H. D., Funk, X., van Elk, M., Graziosi, M., Bauer, P. R., Scheidegger, M., & Yaden, D. B.
(2024). Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for Depression. Psychoactives, 3(2), 215-234.
https://doi.org/10.3390/psychoactives3020014
